Fastest growing Pharmaceuticals stocks over 5-years
| Company | CMP (Rs) | Profit CAGR (5 yrs, %) | Sales CAGR (5 yrs, %) | MCap (Rs m) | P/E (x) | D/E (Curr FY, x) | RoE (5 yrs, Avg. %) |
|---|---|---|---|---|---|---|---|
| WELCURE DRUG | 0.3 | NM | 212.4% | 358 | 1.0 | -3.0 | 22.7% |
| INTRA INFOTECH | 1.9 | NM | 120.3% | 1,015 | NM | 5.1 | 11.1% |
| TRIDENT LIFELINE | 253.5 | NM | 77.5% | 3,025 | 20.1 | 0.8 | 24.7% |
| ACHYUT HEALTHCARE | 4.9 | 108.2% | 55.6% | 1,190 | NM | 0.0 | 1.9% |
| VASA DENTICITY | 399.7 | 182.2% | 52.3% | 6,932 | 54.1 | 0.0 | 45.2% |
| S.S.ORGANICS | 55.5 | NM | 51.5% | 2,054 | NM | -2.5 | 0.0% |
| MAX HEALTHCARE INSTITUTE | 1,050.0 | 142.2% | 46.0% | 1,021,906 | 72.0 | 0.3 | 9.8% |
| BALAXI PHARMA | 25.9 | 32.7% | 45.0% | 1,429 | 15.1 | 0.2 | 27.7% |
| BALAXI PHARMA | 25.9 | 32.7% | 45.0% | 1,429 | 15.1 | 0.2 | 27.7% |
| YATHARTH HOSPITAL | 815.6 | NM | 43.2% | 78,587 | 47.6 | 0.0 | 24.4% |
| SHYAMA INFOSYS | 2.9 | 92.7% | 42.3% | 29 | 15.1 | 0.0 | 1.0% |
| JEENA SIKHO | 637.3 | 73.8% | 37.8% | 79,217 | 44.9 | 0.0 | 33.9% |
| INDEGENE LTD. | 515.9 | 52.6% | 34.6% | 124,269 | 31.0 | 0.0 | 29.0% |
| FERVENT SYNERGIES | 17.1 | 65.8% | 34.6% | 853 | 22.3 | 0.0 | 1.4% |
| ROOPA INDUSTRIES | 54.3 | 40.5% | 34.3% | 427 | 22.1 | 1.9 | 9.1% |
| SANJIVANI PA | 136.3 | NM | 33.8% | 1,674 | 25.0 | 0.2 | 9.2% |
| AMI ORGANICS | 2,730.8 | 42.3% | 33.3% | 223,574 | 62.7 | 0.0 | 15.9% |
| DIPNA PHARMACHEM | 7.5 | 75.2% | 32.5% | 197 | NM | 0.4 | 16.1% |
| SUDEEP PHARMA LTD. | 648.4 | 50.4% | 32.5% | 73,236 | NM | 0.3 | 30.7% |
| FREDUN PHARMA | 2,366.5 | 59.7% | 32.1% | 13,046 | 38.9 | 1.2 | 10.7% |
| BETA DRUGS | 1,565.0 | 35.1% | 31.9% | 16,309 | NM | 0.7 | 22.7% |
| KILITCH DRUGS | 153.0 | 96.9% | 30.1% | 5,349 | 21.5 | 0.2 | 6.7% |
| SIGACHI INDUSTRIES | 20.5 | 28.2% | 28.6% | 7,841 | NM | 0.2 | 18.6% |
| BAFNA PHARMA | 138.0 | NM | 28.0% | 3,265 | 33.8 | 0.3 | 9.6% |
| SOTAC PHARMACEUTICALS LTD. | 111.3 | 154.1% | 27.7% | 1,230 | NM | 0.8 | 18.3% |
* We show NM where the values are negative
Disclaimer: This is for information purposes only. These are not stock recommendations and should not be treated as such. Learn more about our recommendation services here... Also note that these screeners are based only on numbers. There is no screening for management quality.